D. In addition to its
class-leading internal capabilities, LSBC relies on a network of industry,
government and academic collaborators throughout the US and Europe to
achieve rapid, commercially relevant product discovery, optimization and
manufacturing.

patent scientists

can be found on the
company's website (www.predictivediagnostics.researchandmarkets .

biotech straightforward

This release contains forward-looking statements about applications of LSBC
and Predictive Diagnostics' technologies and potential market opportunities
for our diagnostic tests.

purchasing patents

com/cgi-bin /prnh/20040820/RESEARCH )
Dedicated to the drug delivery sector, this report offers a concise and
focused means of assessing and benchmarking drug delivery deal making activity
within the past 8 years. This new edition will provide a completely up-to-date
perspective of the drug delivery sector.

Topics covered include:
- Commercialisation strategies
- Key drivers in drug delivery
- Market value
- Trends in deal terms, upfront, milestone and royalty payments
- The drug delivery deals major pharmaceutical companies are doing
- Valuation methods
- Drug delivery deals since 1996
- Drug delivery companies and their technology focus

The report also includes examples of license agreements

Chapters are entitled as the following:
1 Introduction
2 Market Overview
3 Key Drivers in Drug Delivery
4 Commercialisation Strategies
5 Alliances in Drug Delivery
6 Major Pharmaceutical Company Drug Delivery
7 Valuation Methods
8 Drug Delivery Alliance Development Process
9 Drug Delivery Agreements

For more information visit
http://www.com/reports/c16345

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets .

connects scientists

transfer licensing

The study, done in
conjunction with Jagannadha Avasarala, M. You should not place undue reliance on
these forward-looking statements, which apply only as of the date of this
release.

pharmalicensing patent

LSBC and BAMF are trademarks of Large Scale Biology Corporation.

biotech scientists

Further information about Predictive Diagnostics, Inc.

connects biotech

, a wholly owned
subsidiary of Large Scale Biology Corporation (NASDAQ: LSBC) reported today
that the current issue of the Journal of Molecular Neuroscience has
published the results of Predictive's collaborative research to diagnose
multiple sclerosis using a simple blood test.
This diagnostic analysis was made possible by using Predictive's
proprietary BAMF technology in identifying patterns of proteins and
peptides that distinguish multiple sclerosis patients from those without
MS.com).

contracts dna

About Large Scale Biology Corporation

Large Scale Biology Corporation is a biotechnology company developing and
biomanufacturing biotherapeutics, diagnostic tests, vaccines and industrial
proteins for important life science industry markets. "The granting of this
patent, combined with other patents filed recently to protect the XP-828L
platform, is an important element in our strategy to enhance the value of
our intellectual property portfolio .

The TSX Venture Exchange does not accept responsibility for the adequacy or
accuracy of this release.

dna licensing

straightforward patent

, Ph. These forward-looking statements involve risks,
uncertainties and situations that may cause our actual results to differ
materially from those implied by these statements, including our ability to
commercialize applications of our technologies, the ability of our
collaborators to generate demand for the diagnostic applications, the
effectiveness of our and our collaborators ' technologies to produce
specific diagnostics or provide services and/or in a cost-effective manner ,
any difficulties or delays in obtaining regulatory approval to test and
market such diagnostics or services, and the requirement of substantial
funding for us to preserve our technology base and diagnostic applications. Except as required by law, we do not undertake to update or revise
any forward -looking statement, whether as a result of new information,
future events or otherwise. The reader is cautioned not to rely
on these forward-looking statements.

purchasing patent

Corporate
headquarters, molecular biology and product design laboratories, and
Predictive Diagnostics, Inc. Its main platform, XP-828L , is a bioactive complex
used in the development of an oral treatment for psoriasis and other immune
system disorders.

licensing transfer

At its California laboratory, Predictive
conducts research and development for its diagnostic tests. For more information about Large Scale Biology Corporation,
visit the Company 's website at www. For a further list and description of such risks and uncertainties
see the reports filed by Large Scale Biology Corporation with the
Securities and Exchange Commission, including our reports on Forms 10-K and
10-Q.com
Fax: +353 1 4100 980

Actual results could differ
materially from those projected herein.

purchasing biotech

(Logo: http://www. French corporation Pierre Jouan
Biotechnology, with whom Advitech concluded a licensing agreement, has been
delivered a patent by the French authorities under patent number FR
2827290. The number of common shares outstanding is
54,799,818.

transfer contracts

com.

genetic transfer

In collaborative studies with other institutions, Predictive has
demonstrated the capability of its BAMF technology to accurately
diagnose cancers such as breast, lung, pancreatic and prostate, as well as
Alzheimer's disease.

"We are very happy about this news because it confirms the value of the
intellectual property surrounding XP-828L, our platform for chronic
inflammatory diseases such as psoriasis," stated Renaud Beauchesne,
President and Chief Executive Officer of Advitech .

patenting omrf

com/reports/c16345 ) has announced the addition
of Effective Licensing + Commercialisation of Drug Delivery Systems 2005 to
their offering. It is a critical report
for all those involved in deal making across both the pharmaceutical and
biotechnology sectors.researchandmarkets.

transfer biomedical

Predictive believes its diagnostic tests will provide
better patient outcome through early detection of cancer and other serious
diseases and significantly reduce the cost of healthcare associated with
treatment of such diseases. DUBLIN, Ireland, Research and Markets
(http://www. Advitech's common shares are listed on the TSX Venture
Exchange under the symbol AVI. The forward-looking
statements involve risks and uncertainties.

arthritis transfer

It details valuation methodologies and explores
effective deal structuring to ensure maximum returns. Its key focus areas are in the fields of immunology and
inflammatory processes .

This press release contains forward-looking statements which reflect the
Company's current expectations regarding future events.

omrf purchasing

, while at Wake Forest
University Baptist Medical Center, is the first published research of its
kind to describe a potential diagnostic blood test for multiple sclerosis.lsbc."

About Advitech

Advitech specializes in the development of bioactive products derived from
dairy proteins.

patented pharmaceuticals

PRESS RELEASE Blood Test for Multiple Sclerosis Described in Journal of Molecular Neuroscience

It includes over 1400 drug delivery
deals, over 50 drug delivery contracts and the latest company information.
Advitech (TSX-V: AVI), a Canadian
biotech company involved in the development of a new oral treatment for
psoriasis, announced today that it has substantially strengthened its
intellectual property position.

commercialization patented

Predictive Diagnostics, Inc.

According to the license, Advitech has the right to use Jouan's technology
in the development of products targeting inflammatory diseases resulting
from immune system disorders. These
applications are currently pending.

commercialization connects

, are located in Vacaville, California, and the
Company's bioprocess development and commercial -scale biomanufacturing
facilities are located in Owensboro, Kentucky.
We cannot guarantee future results.newscom.

Advitech Reinforces Its Intellectual Property Position: Granted Important Patent

connects patenting

Research and Markets: View This Critical Report If You are Involved in Deal Making Across Both the Pharmaceutical and Biotechnology Sectors

Jouan's patent has also been filed in the
United States, Canada and in many other European and Asian countries. The Company disclaims any obligation
to update these forward-looking statements.